|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.228 EUR | -0.13% |
|
+10.19% | +14.28% |
| 06-22 | Evolus, Inc.(NasdaqGM:EOLS) added to S&P Pharmaceuticals Select Industry Index | CI |
| 05-11 | Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe | CI |
| Market Cap | 470M 412M 379M 355M 666M 44.29B 680M 4.56B 1.76B 21.89B 1.76B 1.72B 75.91B | P/E 2026 * |
-14.4x | P/E 2027 * | -48.6x |
|---|---|---|---|---|---|
| Enterprise Value | 597M 523M 482M 451M 846M 56.27B 864M 5.79B 2.24B 27.81B 2.24B 2.19B 96.44B | EV / Sales 2026 * |
1.81x | EV / Sales 2027 * | 1.55x |
| Free-Float |
83.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evolus, Inc.
| 1 week | +10.19% | ||
| Current month | +12.22% | ||
| 1 month | +16.54% | ||
| 3 months | +71.10% | ||
| 6 months | +5.56% | ||
| Current year | +14.28% |
| 1 week | 5.52 |  | 6.27 |
| 1 month | 4.98 | | 6.27 |
| 3 years | 3.36 | | 16.1 |
| 5 years | 3.36 | | 16.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Moatazedi
CEO | Chief Executive Officer | 48 | 06/05/2018 |
Tatjana Mitchell
DFI | Director of Finance/CFO | 48 | 08/09/2025 |
Jon Yerbury
COO | Chief Operating Officer | - | 01/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vikram Malik
CHM | Chairman | 63 | 01/01/2018 |
David Gill
BRD | Director/Board Member | 71 | 12/02/2018 |
David Moatazedi
BRD | Director/Board Member | 48 | 06/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | +10.19% | -20.15% | -8.41% | 470M | |
| +7.13% | +9.97% | +55.80% | +160.09% | 1,077B | |
| +3.99% | +11.50% | +67.09% | +55.96% | 613B | |
| +4.20% | +17.03% | +38.97% | +91.06% | 448B | |
| +0.99% | +4.85% | +28.17% | +23.89% | 332B | |
| +1.82% | +8.19% | +40.04% | +27.95% | 293B | |
| +0.22% | +6.75% | +31.30% | +42.34% | 286B | |
| +0.73% | +8.53% | -27.33% | -39.55% | 215B | |
| +1.56% | +6.14% | +29.30% | +60.97% | 193B | |
| +3.26% | +3.33% | +15.55% | +68.24% | 159B | |
| Average | +2.66% | +8.00% | +25.87% | +48.25% | 401.79B | |
| Weighted average by Cap. | +3.85% | +8.93% | +41.75% | +80.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 330M 290M 267M 250M 469M 31.17B 479M 3.21B 1.24B 15.41B 1.24B 1.21B 53.42B | 388M 340M 313M 293M 550M 36.57B 561M 3.77B 1.46B 18.07B 1.46B 1.42B 62.67B |
| Net income | -33.31M -29.2M -26.92M -25.2M -47.26M -3.14B -48.24M -324M -125M -1.55B -125M -122M -5.38B | -10.56M -9.26M -8.54M -7.99M -14.99M -996M -15.3M -103M -39.7M -492M -39.66M -38.79M -1.71B |
| Net Debt | 127M 111M 103M 96.09M 180M 11.98B 184M 1.23B 477M 5.92B 477M 466M 20.53B | 132M 116M 107M 99.88M 187M 12.45B 191M 1.28B 496M 6.15B 496M 485M 21.34B |
| Date | Price | Change |
|---|---|---|
| 26/06/26 | €6.228 | -0.13% |
| 25/06/26 | €6.236 | +2.26% |
| 24/06/26 | €6.098 | +3.71% |
| 23/06/26 | €5.880 | +1.91% |
| 22/06/26 | €5.770 | +2.09% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EOLS Stock
- EVL Stock
Select your edition
All financial news and data tailored to specific country editions
